Results 21 to 30 of about 2,955,835 (214)

Antihypertensive Medication Adherence and Risk of Cardiovascular Disease Among Older Adults: A Population‐Based Cohort Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundAntihypertension medication (antihypertensive) adherence lowers risk of cardiovascular disease (CVD); few studies have examined this association among older adults.
Quanhe Yang, Anping Chang, Matthew D. Ritchey, Fleetwood Loustalot   +3 more
doaj   +1 more source

Risk of Cardiovascular Disease After COVID‐19 Diagnosis Among Adults With and Without Diabetes

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Growing evidence suggests incident cardiovascular disease (CVD) may be a long‐term outcome of COVID‐19 infection, and chronic diseases, such as diabetes, may influence CVD risk associated with COVID‐19.
Alain K. Koyama, Giuseppina Imperatore, Deborah B. Rolka, Elizabeth Lundeen, Rachel E. Rutkowski, Sandra L. Jackson, Siran He, Elena V. Kuklina, Soyoun Park, Meda E. Pavkov   +9 more
doaj   +1 more source

Nutrition and Stroke Prevention [PDF]

Stroke, 2006
Nutrition is much more important in prevention of stroke than is appreciated by most physicians. The powerful effects of statin drugs in lowering the levels of fasting cholesterol, combined with an unbalanced focus on fasting lipids (as opposed to postprandial fat and oxidative stress), have led many physicians and patients to believe that
Marc Fisher, Kennedy Lees, J. David Spence   +2 more
openaire   +4 more sources

Policy implementation strategies to address rural disparities in access to care for stroke patients

Frontiers in Health Services, 2023
ContextStroke systems of care (SSOC) promote access to stroke prevention, treatment, and rehabilitation and ensure patients receive evidence-based treatment.
Aysha Rasool, Aysha Rasool, Moriah Bailey, Brittany Lue, Nina Omeaku, Adebola Popoola, Sharada S. Shantharam, Amanda A. Brown, Erika B. Fulmer   +8 more
doaj   +1 more source

Inflammation and Stroke Risk: A New Target for Prevention.

Stroke, 2021
New therapeutic approaches are required for secondary prevention of residual vascular risk after stroke. Diverse sources of evidence support a causal role for inflammation in the pathogenesis of stroke.
P. Kelly, R. Lemmens, G. Tsivgoulis
semanticscholar   +1 more source

Time Course of Evolution of Disability and Cause‐Specific Mortality After Ischemic Stroke: Implications for Trial Design

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundOutcome in stroke trials is often based on a 3‐month modified Rankin scale (mRS). How 3‐month mRS relates to longer‐term outcomes will depend on late recovery, delayed stroke‐related deaths, recurrent strokes, and nonstroke deaths. We evaluated
Aravind Ganesh, Ramon Luengo‐Fernandez, Rose M. Wharton, Sergei A. Gutnikov, Louise E. Silver, Ziyah Mehta, Peter M. Rothwell   +6 more
doaj   +1 more source

Stroke Prevention

Delaware Journal of Public Health, 2023
Stroke has three main subtypes - ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. The most common stroke subtype is ischemic stroke, making up about 88% of strokes. Many of these strokes may be prevented by lifestyle modifications.
openaire   +2 more sources

Interventions Targeting Racial/Ethnic Disparities in Stroke Prevention and Treatment

Stroke, 2020
Systemic racism is a public health crisis. Systemic racism and racial/ethnic injustice produce racial/ethnic disparities in health care and health.
D. Levine, P. Duncan, Mai N. Nguyen-Huynh, Olugbenga Ogedegbe   +3 more
semanticscholar   +1 more source

European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack

European Stroke Journal, 2022
Recurrent stroke affects 9% to 15% of people within 1 year. This European Stroke Organisation (ESO) guideline provides evidence-based recommendations on pharmacological management of blood pressure (BP), diabetes mellitus, lipid levels and antiplatelet ...
J. Dawson, Y. Béjot, L. Christensen, G. D. De Marchis, M. Dichgans, G. Hagberg, M. Heldner, H. Milionis, Linxin Li, F. Pezzella, Martin Taylor Rowan, C. Tiu, A. Webb   +12 more
semanticscholar   +1 more source

Prevalence and outcomes of frailty in unplanned hospital admissions: a systematic review and meta-analysis of hospital-wide and general (internal) medicine cohortsResearch in context

EClinicalMedicine, 2023
Summary: Background: Guidelines recommend routine frailty screening for all hospitalised older adults to inform care decisions, based mainly on studies in elective or speciality-specific settings.
Emily L. Boucher, Jasmine M. Gan, Peter M. Rothwell, Sasha Shepperd, Sarah T. Pendlebury   +4 more
doaj   +1 more source